These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38981961)

  • 1. Canada's approach to SARS-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics.
    O'Brien SF; Asamoah-Boaheng M; Grunau B; Krajden M; Buckeridge DL; Goldfarb DM; Anderson M; Germain M; Brown P; Stein DR; Kandola K; Tipples G; Awadalla P; Lang A; Behl L; Fitzpatrick T; Drews SJ
    Can J Public Health; 2024 Aug; 115(4):558-566. PubMed ID: 38981961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Implementation of Dried Blood Spot-Based COVID-19 Serological Assays for Epidemiologic Studies.
    Wong MP; Meas MA; Adams C; Hernandez S; Green V; Montoya M; Hirsch BM; Horton M; Quach HL; Quach DL; Shao X; Fedrigo I; Zermeno A; Huffaker J; Montes R; Madden A; Cyrus S; McDowell D; Williamson P; Contestable P; Stone M; Coloma J; Busch MP; Barcellos LF; Harris E
    Microbiol Spectr; 2022 Jun; 10(3):e0247121. PubMed ID: 35612315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidance.
    Cramer EY; Snyder T; Ravenhurst J; Lover AA
    BMC Public Health; 2022 Oct; 22(1):1907. PubMed ID: 36224583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response.
    Siegler AJ; Sullivan PS; Sanchez T; Lopman B; Fahimi M; Sailey C; Frankel M; Rothenberg R; Kelley CF; Bradley H
    Ann Epidemiol; 2020 Sep; 49():50-60. PubMed ID: 32791199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sero-Surveillance to Monitor the Trend of SARS-CoV-2 Infection Transmission in India: Study Protocol for a Multi Site, Community Based Longitudinal Cohort Study.
    Nair D; Raju R; Roy S; Dandge S; Chethrapilly Purushothaman GK; Jayaraman Y; Kangusamy B; Shrivastava R; Arora NK; Rose W; Juvekar S; Jammy GR; Singh K; Mehendale S; Rajkumar P; Malik ST
    Front Public Health; 2022; 10():810353. PubMed ID: 35400044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership.
    COVID-19 Community Research Partnership Study Group
    BMC Infect Dis; 2021 Aug; 21(1):889. PubMed ID: 34461847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online survey.
    Lim E; Mehrotra ML; Lamba K; Kamali A; Lai KW; Meza E; Bertsch-Merbach S; Szeto I; Ley C; Martin AB; Parsonnet J; Robinson P; Gebhart D; Fonseca N; Tsai CT; Seftel D; Nicolici A; Melton D; Jain S
    BMC Med Res Methodol; 2024 May; 24(1):120. PubMed ID: 38802749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 sero-prevalence in the workforces of three large workplaces in South Wales: a sero-epidemiological study.
    Puchades A; Daniel R; Geen J; Peden J; Lewis H; Nnoaham K
    BMC Public Health; 2022 Jan; 22(1):162. PubMed ID: 35073884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
    Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
    JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canada's provincial COVID-19 pandemic modelling efforts: A review of mathematical models and their impacts on the responses.
    Xia Y; Flores Anato JL; Colijn C; Janjua N; Irvine M; Williamson T; Varughese MB; Li M; Osgood N; Earn DJD; Sander B; Cipriano LE; Murty K; Xiu F; Godin A; Buckeridge D; Hurford A; Mishra S; Maheu-Giroux M
    Can J Public Health; 2024 Aug; 115(4):541-557. PubMed ID: 39060710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 pandemic in Saint Petersburg, Russia: Combining population-based serological study and surveillance data.
    Barchuk A; Skougarevskiy D; Kouprianov A; Shirokov D; Dudkina O; Tursun-Zade R; Sergeeva M; Tychkova V; Komissarov A; Zheltukhina A; Lioznov D; Isaev A; Pomerantseva E; Zhikrivetskaya S; Sofronova Y; Blagodatskikh K; Titaev K; Barabanova L; Danilenko D
    PLoS One; 2022; 17(6):e0266945. PubMed ID: 35704649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance.
    Kumar MS; Bhatnagar T; Manickam P; Kumar VS; Rade K; Shah N; Kant S; Babu GR; Zodpey S; Girish Kumar CP; Vivian Thangaraj JW; Chatterjee P; Kanungo S; Pandey RM; Murhekar M; Singh SK; Sarkar S; Muliyi JP; Gangakhedkar RR; Reddy DCS
    Indian J Med Res; 2020 May; 151(5):419-423. PubMed ID: 32611913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riding high: seroprevalence of SARS-CoV-2 after 4 pandemic waves in Manitoba, Canada, April 2020-February 2022.
    Duong S; Burtniak J; Gretchen A; Mai A; Klassen P; Wei Y; Loeppky C; Shaw SY; Bullard J; Van Caeseele P; Stein DR
    BMC Public Health; 2023 Dec; 23(1):2420. PubMed ID: 38053033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian COVID-19 Outbreak Surveillance System: implementation of national surveillance during a global pandemic.
    McGill E; Coulby C; Dam D; Bellos A; McCormick R; Patterson K
    Can J Public Health; 2023 Jun; 114(3):358-367. PubMed ID: 37074555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
    Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
    JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
    Sudre CH; Keshet A; Graham MS; Joshi AD; Shilo S; Rossman H; Murray B; Molteni E; Klaser K; Canas LD; Antonelli M; Nguyen LH; Drew DA; Modat M; Pujol JC; Ganesh S; Wolf J; Meir T; Chan AT; Steves CJ; Spector TD; Brownstein JS; Segal E; Ourselin S; Astley CM
    Lancet Digit Health; 2021 Sep; 3(9):e577-e586. PubMed ID: 34305035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.